XTL Biopharmaceuticals Ltd. (XTLB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    XTL Biopharmaceuticals Lt...

    NASDAQ: XTLB · Real-Time Price · USD
    1.18
    0.01 (0.85%)
    At close: Oct 03, 2025, 3:48 PM
    1.17
    -0.85%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    XTL Biopharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -13.3 -3.09K -4.89 33.88
    PEG Ratio
    		 n/a 30.89 0.01 -0.3
    PS Ratio
    		 30.29 n/a n/a n/a
    PB Ratio
    		 2.51 2.48 1.65 2.76
    P/FCF Ratio
    		 -8.17 -7.79 -7.32 -14.05
    P/OCF Ratio
    		 -8.44 -7.79 -7.32 -14.05
    OCF/S Ratio
    		 -3.59 n/a n/a n/a
    Debt / Equity Ratio
    		 0.03 n/a n/a n/a
    Quick Ratio
    		 0.61 9.93 20.35 27.00
    Current Ratio
    		 0.61 9.93 20.35 27.00
    Asset Turnover
    		 0.05 n/a n/a n/a
    Interest Coverage
    		 -25.26 -191.3 -80.01 -49.1
    Return on Equity
    		 -0.19 n/a -0.34 0.08
    Return on Assets
    		 -0.12 n/a -0.32 0.07
    Return on Invested Capital
    		 -0.3 -0.34 -0.22 -0.16
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.01 n/a n/a n/a
    Net Profit Margin
    		 -2.28 n/a n/a n/a
    Pretax Profit Margin
    		 -2.57 n/a n/a n/a
    Operating Profit Margin
    		 -4.82 n/a n/a n/a
    FCF Margin
    		 -3.71 n/a n/a n/a
    EBITDA Margin
    		 -2.06 n/a n/a n/a

    Add to Watchlist